166 related articles for article (PubMed ID: 38536628)
1. Evaluation of the histologic and immunohistochemical (CD34, glutamine synthetase) findings in idiopathic non-cirrhotic portal hypertension (INCPH).
Büyük M; Berker N; Bakkaloğlu DV; Şenkal İV; Önal Z; Güllüoğlu M
Hepatol Int; 2024 Jun; 18(3):1011-1019. PubMed ID: 38536628
[TBL] [Abstract][Full Text] [Related]
2. Aberrant von Willebrand factor expression of sinusoidal endothelial cells and quiescence of hepatic stellate cells in nodular regenerative hyperplasia and obliterative portal venopathy.
Zhang X; Thomas C; Schiano TD; Thung SN; Ward SC; Fiel MI
Histopathology; 2020 Jun; 76(7):959-967. PubMed ID: 31994248
[TBL] [Abstract][Full Text] [Related]
3. Histological features in western patients with idiopathic non-cirrhotic portal hypertension.
Verheij J; Schouten JN; Komuta M; Nevens F; Hansen BE; Janssen HL; Roskams T
Histopathology; 2013 Jun; 62(7):1083-91. PubMed ID: 23600724
[TBL] [Abstract][Full Text] [Related]
4. Key histopathologic features in idiopathic noncirrhotic portal hypertension: an interobserver agreement study and proposal for diagnostic criteria.
Liang J; Shi C; Dupont WD; Salaria SN; Huh WJ; Correa H; Roland JT; Perri RE; Washington MK
Mod Pathol; 2021 Mar; 34(3):592-602. PubMed ID: 32958831
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of histological features of idiopathic noncirrhotic portal hypertension in general population: a retrospective study of incidental liver biopsies.
Zuo C; Chumbalkar V; Ells PF; Bonville DJ; Lee H
Hepatol Int; 2017 Sep; 11(5):452-460. PubMed ID: 28597108
[TBL] [Abstract][Full Text] [Related]
6. Histological Spectrum of Idiopathic Noncirrhotic Portal Hypertension in Liver Biopsies From Dialysis Patients.
Lee H; Ainechi S; Singh M; Ells PF; Sheehan CE; Lin J
Int J Surg Pathol; 2015 Sep; 23(6):439-46. PubMed ID: 25882443
[TBL] [Abstract][Full Text] [Related]
7. Interobserver study on histologic features of idiopathic non-cirrhotic portal hypertension.
Kmeid M; Zuo C; Lagana SM; Choi WT; Lin J; Yang Z; Liu X; Westerhoff M; Fiel MI; Affolter K; Choi EK; Lee H
Diagn Pathol; 2020 Oct; 15(1):129. PubMed ID: 33097074
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.
Barge S; Grando V; Nault JC; Broudin C; Beaugrand M; Ganne-Carrié N; Roulot D; Ziol M
Liver Int; 2016 Jul; 36(7):1059-66. PubMed ID: 26415006
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic challenges of focal nodular hyperplasia: interobserver variability, accuracy, and the utility of glutamine synthetase immunohistochemistry.
Rowan DJ; Allende DS; Bellizzi AM; Gill RM; Liu X; McKenzie CA; Moreira RK; Mounajjed T; Said S; Westerhoff M; Jenkins SM; Batts KP; Burgart LJ; Lamps LW; Graham RP
Histopathology; 2021 Nov; 79(5):791-800. PubMed ID: 34080211
[TBL] [Abstract][Full Text] [Related]
10. Utility of glutamine synthetase immunohistochemistry in identifying features of regressed cirrhosis.
Hadi R; Shin K; Reder N; Alpert L; Koch L; Choi WT; Swanson PE; Hart J; Westerhoff M
Mod Pathol; 2020 Mar; 33(3):448-455. PubMed ID: 31391527
[TBL] [Abstract][Full Text] [Related]
11. Etiological analysis of focal nodular hyperplasia of the liver, with emphasis on similar abnormal vasculatures to nodular regenerative hyperplasia and idiopathic portal hypertension.
Kondo F; Nagao T; Sato T; Tomizawa M; Kondo Y; Matsuzaki O; Wada K; Wakatsuki S; Nagao K; Tsubouchi H; Kobayashi H; Yasumi K; Tsukayama C; Suzuki M
Pathol Res Pract; 1998; 194(7):487-95. PubMed ID: 9728365
[TBL] [Abstract][Full Text] [Related]
12. Pathology of idiopathic non-cirrhotic portal hypertension.
Guido M; Sarcognato S; Sacchi D; Colloredo G
Virchows Arch; 2018 Jul; 473(1):23-31. PubMed ID: 29644430
[TBL] [Abstract][Full Text] [Related]
13. Peritumoral hyperplasia of the liver: a response to portal vein invasion by hypervascular neoplasms.
Arnason T; Fleming KE; Wanless IR
Histopathology; 2013 Feb; 62(3):458-64. PubMed ID: 23240735
[TBL] [Abstract][Full Text] [Related]
14. Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition.
Guido M; Alves VAF; Balabaud C; Bathal PS; Bioulac-Sage P; Colombari R; Crawford JM; Dhillon AP; Ferrell LD; Gill RM; Hytiroglou P; Nakanuma Y; Paradis V; Quaglia A; Rautou PE; Theise ND; Thung S; Tsui WMS; Sempoux C; Snover D; van Leeuwen DJ;
Histopathology; 2019 Jan; 74(2):219-226. PubMed ID: 30129657
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis.
Stevenson HL; Prats MM; Sasatomi E
BMC Cancer; 2017 Jan; 17(1):35. PubMed ID: 28061766
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic noncirrhotic portal hypertension.
Schouten JN; Garcia-Pagan JC; Valla DC; Janssen HL
Hepatology; 2011 Sep; 54(3):1071-81. PubMed ID: 21574171
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.
Ahmad I; Iyer A; Marginean CE; Yeh MM; Ferrell L; Qin L; Bifulco CB; Jain D
Hum Pathol; 2009 May; 40(5):726-34. PubMed ID: 19157505
[TBL] [Abstract][Full Text] [Related]
18. Abdominal Surgery in Patients With Idiopathic Noncirrhotic Portal Hypertension: A Multicenter Retrospective Study.
Elkrief L; Ferrusquia-Acosta J; Payancé A; Moga L; Tellez L; Praktiknjo M; Procopet B; Farcau O; De Lédinghen V; Yuldashev R; Tabchouri N; Barbier L; Dumortier J; Menahem B; Magaz M; Hernández-Gea V; Albillos A; Trebicka J; Spahr L; De Gottardi A; Plessier A; Valla D; Rubbia-Brandt L; Toso C; Bureau C; Garcia-Pagan JC; Rautou PE;
Hepatology; 2019 Sep; 70(3):911-924. PubMed ID: 30924941
[TBL] [Abstract][Full Text] [Related]
19. Nodular Regenerative Hyperplasia: Expression Pattern of Glutamine Synthetase and a Potential Role for Hepatic Progenitor Cells.
Guilbert MC; Therrien A; Soucy G; Trudel D; Nguyen BN
Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):243-248. PubMed ID: 31335486
[TBL] [Abstract][Full Text] [Related]
20. Mild changes of hepatic nodular regenerative hyperplasia may cause portal hypertension and be visible on reticulin but not hematoxylin and eosin staining.
Navale P; Gonzalez RS
Virchows Arch; 2021 Dec; 479(6):1145-1152. PubMed ID: 34435237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
